Fluticasone Propionate
Product Images NDC 53217-164

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 53217-164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula (Fluticasone Propionate 1)

Chemical structure of fluticasone propionate showing its detailed steroid backbone with fluorine, methyl, hydroxyl, and ester functional groups as labeled in the diagram.*

FDA Label Image

Table1 (Fluticasone Propionate 2)

A table titled 'Drug-Related Adverse Events - Skin' presenting the incidence of various skin-related adverse events in patients using Fluticasone Propionate once daily, twice daily, and a vehicle twice daily. The table includes events like skin infection, eczema types, viral warts, herpes simplex, erythema, burning, skin irritation, pruritis, folliculitis, and dryness of skin, with corresponding patient counts and percentages for each treatment group.*

FDA Label Image

Table2 (Fluticasone Propionate 3)

A table titled 'Adverse Events From Pediatric Open-Label Trial (n=51)' listing adverse events and their frequency in patients taking Fluticasone twice daily. Events include burning, dusky erythema, erythematous rash, facial telangiectasia, non-facial telangiectasia, and urticaria, with occurrences ranging from 1 to 2 cases and percentages from 2.0% to 4.9%.*

FDA Label Image

Table3 (Fluticasone Propionate 4)

A data table titled 'Table 3: Physician's Assessment of Clinical Response' comparing clinical response categories for Fluticasone Propionate Cream versus Vehicle across two studies each. The table presents percentage distributions for categories including Cleared, Excellent, Good, Fair, Poor, and Worse for patient groups in Study 1 and Study 2 for both treatments.*

FDA Label Image

Table4 (Fluticasone Propionate 5)

A data table titled "Table 4: Clinical Signs: Mean Improvements Over Baseline" comparing mean improvements for erythema, thickening, and scaling between Fluticasone Propionate Cream and Vehicle across two studies. The table presents numerical values for each condition in Study 1 and Study 2, showing higher improvements for Fluticasone Propionate Cream compared to Vehicle.*

FDA Label Image

Table5 (Fluticasone Propionate 6)

Data table titled 'Physician’s Assessment of Clinical Response' comparing clinical responses for Fluticasone Propionate Cream administered once daily versus twice daily across two studies. The table categorizes responses as Cleared, Excellent, Good, Fair, Poor, and Worse with corresponding percentages for each study group.*

FDA Label Image

Table6 (Fluticasone Propionate 7)

A data table titled 'Clinical Signs and Symptoms: Mean Improvements Over Baseline' comparing two studies on Fluticasone Propionate Cream dosed once daily and twice daily. The table lists mean improvement scores for erythema, pruritis, thickening, lichenification, vesiculation, and crusting across both dosing regimens and studies.*

FDA Label Image

Image Description (Fluticasone Propionate 8)

Fluticasone Propionate 0.05% cream 15 gram tube label from Aidarex Pharmaceuticals LLC. The label indicates the generic product for Cutivate with directions to apply multiple times daily and includes manufacturing and packaging information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.